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Abstract
Protein phosphorylation is a key mediator of signal transduction, allowing for dynamic regulation 
of substrate activity. Whereas protein kinases obtain substrate specificity by targeting specific 
amino acid sequences, serine/threonine phosphatase catalytic subunits are much more 
promiscuous in their ability to dephosphorylate substrates. To obtain substrate specificity, serine/
threonine phosphatases utilize targeting proteins to regulate phosphatase subcellular localization 
and catalytic activity. Spinophilin and its homologue neurabin are two of the most abundant 
dendritic spine-localized protein phosphatase 1 (PP1) targeting proteins. The association between 
spinophilin and PP1 is increased in the striatum of animal models of Parkinson’s disease (PD). 
However, mechanisms that regulate the association of spinophilin and neurabin with PP1 are 
unclear. Here, we report that the association between spinophilin and PP1α or PP1γ1 was 
increased by CDK5 expression and activation in a heterologous cell system. This increased 
association is at least partially due to phosphorylation of PP1. Conversely, CDK5 expression and 
activation decreased the association of PP1 with neurabin. As with dopamine depletion, 
methamphetamine (METH) abuse causes persistent alterations in dopamine signaling which 
influence striatal medium spiny neuron function and biochemistry. Moreover, both METH toxicity 
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and dopamine depletion are associated with deficits in motor control and motor learning. 
Pathologically, we observed a decreased association of spinophilin with PP1 in rat striatum 
evaluated one month following a binge METH paradigm. Behaviorally, we found that loss of 
spinophilin recapitulates rotarod pathology previously observed in dopamine-depleted and METH-
treated animals. Together, these data have implications in multiple disease states associated with 
altered dopamine signaling such as PD and psychostimulant drug abuse and delineate a novel 
mechanism by which PP1 interactions with spinophilin and neurabin may be differentially 
regulated.
Graphical Abstract
Keywords
Phosphatase; methamphetamine; signaling; scaffolding proteins
INTRODUCTION
Spinophilin is a protein phosphatase 1 (PP1) targeting protein that is enriched in dendritic 
spines.1,2 Spinophilin is critical in regulating normal synaptic physiology by directing PP1 
to its targets such as glutamate receptors.3–8 Spinophilin interaction with PP1 is increased in 
both rat and mouse models of Parkinson’s disease (PD)9,10 and the expression of spinophilin 
is up-regulated following chronic amphetamine treatment.11,12 In addition to alterations in 
spinophilin interactions and expression, loss of spinophilin enhances cocaine-induced 
condition-place preference.13 Therefore, spinophilin expression is regulated by 
psychostimulants, and spinophilin modulates behavioral responses to psychostimulants. 
However, the mechanisms that underlie dopamine-dependent pathological changes in the 
spinophilin/PP1 interaction and how spinophilin contributes to striatal motor behaviors are 
not known. Therefore, the goals of the current study were to define novel mechanisms that 
are associated with dopamine modulation that regulate the spinophilin/PP1 interaction and 
delineate spinophilin regulation of motor behaviors and learning.
A specific binding domain on spinophilin containing residues 417–494 is necessary and 
sufficient for PP1 binding.14 PP1 binding occurs via four unique regions within this domain 
on spinophilin.15 These unique regions allow for substrate selectivity in the targeting of PP1. 
There are four isoforms of PP1: PP1α, PP1β, PP1γ1, and PP1γ2. While all isoforms are 
present, PP1α, PP1β, and PP1γ1 are highly expressed in the brain.16–19 PP1α and PP1γ1 
are enriched in dendritic spines, whereas PP1β is localized to dendrites. Spinophilin 
associates with PP1γ1 but has less robust association with PP1β.20,21 As stated above, 
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dopamine depletion, an animal model of Parkinson’s disease, increases the association of 
spinophilin with PP1;9,10 however, the mechanisms regulating this association are unclear. 
One putative mode by which the spinophilin PP1 interaction may be regulated is by 
alterations in phosphorylation of spinophilin and/or PP1. Interestingly, a recent study 
demonstrated that protein kinase A (PKA) activity can modulate the association of neurabin, 
but not spinophilin, with PP1.22 This altered association is due to differences in 
phosphorylation of neurabin within its PP1-binding domain. A previous study found that 
cyclin-dependent kinase 5 (CDK5) activity is increased in dopamine depleted animals.23 
CDK5 phosphorylates spinophilin at Ser-17 within the N-terminal actin-binding domain,24 a 
site that has increased phosphorylation in an animal model of PD.10 In addition to 
spinophilin, PP1α is phosphorylated by CDK5 at Thr320.25 Moreover, PP1γ1 has a 
conserved Thr at residue 311 that may also be phosphorylated by the kinase.
Methamphetamine (METH) is an addictive psychostimulant drug of abuse that, when given 
at high doses, can lead to dopamine toxicity in rodents.26,27 METH abusers have a higher 
incidence of developing PD,28 and METH toxicity can lead to behavioral sensitization to 
dopamine agonists.29 Also, both dopamine depletion and METH toxicity are associated with 
motor coordination and/or motor learning deficits.30–32 Biochemically, alterations in 
dopamine release and levels in the synapse regulate normal synaptic protein function and 
signaling. Here, we report that a binge model of METH decreases the association of 
spinophilin with PP1 and that CDK5 phosphorylation of PP1 enhances the spinophilin/PP1 
interaction. Moreover, we have observed that loss of spinophilin recapitulates motor 
coordination and learning deficits observed in dopamine depletion and METH toxicity. 
Taken together, these data give novel insight into spinophilin function in striatal-based motor 
behaviors as well as mechanistic changes that occur under pathological dopamine conditions 
that may regulate the spinophilin/PP1 interaction.
RESULTS
PP1 Overexpression in a Heterologous Cell System.
PP1 is a critical regulator of the phosphorylation of multiple substrates, and spinophilin is 
the major PP1 targeting enzyme in the PSD.33 Of the three PP1 isoforms, spinophilin does 
not robustly bind PP1β20 but does bind PP1α and PP1γ1. To begin to delineate mechanisms 
that modulate the association of spinophilin with PP1α and PP1γ1, we used a heterologous 
cell system (HEK293). However, we first needed to determine which PP1 isoforms are 
expressed in this cell system. To delineate the expression of different PP1 isoforms in a 
heterologous cell system, we overexpressed myc-tagged rat PP1γ1 (which differs from 
human PP1γ1 only by a Leu/Ile change at position 4) and myc-tagged human PP1α in 
HEK293 cells. We found that both PP1α and PP1γ1 were equally overexpressed using a 
myc-tag antibody (Figure 1A). We utilized a mouse PP1 antibody that was raised against 
full-length, human PP1α and a goat antibody raised against full-length, human PP1γ (see 
Methods). Although there were equal amounts of PP1 transfected, as detected by the myc 
antibody (Figure 1A left panel and Figure 1B left panel), the mouse-PP1α antibody 
selectively (~31.3 times) detected PP1α (Figures 1A and B middle panel), whereas the goat-
PP1γ1 antibody selectively (~13.5 times) detected PP1γ1 (Figures 1A and 1B right panel). 
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Interestingly, the mouse-PP1α antibody detected endogenous PP1 that migrated at 37 kDa, 
whereas the goat-PP1γ1 antibody detected a band that migrated slightly below 37 kDa 
(Figure 1A). This is consistent with the predicted mass of human PP1α (37 512 Da) and 
PP1γ1 (36 984 Da). To determine endogenous expression of PP1α and PP1γ1, we 
normalized for antibody differences by normalizing the detection of overexpressed PP1α or 
PP1γ1 to the corresponding signal detected in the myc immunoblot (Figure 1A left panel). 
This allows us to account for differences in detection efficiency between antibodies. It is 
important to note that the specificity of these antibodies may be influenced by dilution, and 
we use a 1:1000–1:2000 primary antibody dilution for these studies. Following additional 
normalization to loading (normalized to ponceau), we conclude that endogenous PP1α and 
PP1γ1 were detected at equal amounts (Figure 1C). This suggests that endogenous PP1α 
and PP1γ1 are expressed at similar levels in HEK293 cells. Interestingly, overexpression of 
PP1α enhanced the detection of a PP1α band migrating at the level of the endogenous 
PP1α, whereas overexpression of PP1γ1 enhanced the detection of a PP1γ1 band migrating 
at the level of endogenous PP1γ1 (Figure 1D). While we predict this band is endogenous 
PP1, it may be a fragment of the N-terminally tagged Myc-PP1. Conversely, overexpression 
of PP1α decreased endogenous PP1γ1 expression, whereas overexpression of PP1γ1 
decreased endogenous PP1α expression (Figure 1D). Together, these data suggest that both 
PP1α and PP1γ1 are expressed in HEK293 cells at similar levels and that these two PP1 
isoforms can regulate both their own expression and expression of the other isoform.
Spinophilin Interaction with Both PP1α and PP1γ1 is Enhanced by CDK5.
We previously found that spinophilin association with PP1 is increased in dopamine-
depleted striatum.9,10 Dopamine activates its receptors to regulate PKA and CDK5 activity.
23,34–38
 HA-tagged spinophilin was overexpressed in the absence or presence of CDK5 and 
its activator, p35, in HEK293 cells. We evaluated the association between spinophilin and 
endogenous PP1α and PP1γ1 (Figure 2A). Overexpression of CDK5 and its activator p35 
increased the association between spinophilin and endogenous PP1α and PP1γ1 (Figure 2B) 
in HEK293 cells. This increased association was not due to increased expression of 
spinophilin or PP1 because, in the presence of CDK5, spinophilin expression was ~34% 
lower (Figure 2C), whereas PP1 expression was unchanged (Figure 2D). Together, these data 
demonstrate that overexpression of CDK5 along with its activator p35 increases the amount 
of endogenous PP1 coprecipitated with overexpressed spinophilin.
Neurabin/PP1 Interaction Is Decreased by CDK5.
The spinophilin homologue, neurabin, is also a major PP1 targeting protein in the brain.39,40 
Neurabin associates with both PP1α and PP1γ1 at a similar stoichiometry as spinophilin39 
but has different localization and functional roles when compared with spinophilin.1,13 
Therefore, we wanted to determine if the association of neurabin with PP1α and/or PP1γ1 
was also regulated by CDK5. HA-tagged neurabin was overexpressed in the absence or 
presence of overexpressed CDK5 and p35 (Figure 3A). In contrast to what was observed 
with spinophilin, PP1α and PP1γ1 association with neurabin was decreased (Figure 3B). 
Like spinophilin, neurabin expression was decreased in the presence of CDK5 and p35; 
however, this decrease was greater at ~64% (Figure 3C). Moreover, for neurabin, we 
observed a modest molecular weight shift in the presence of CDK5, whereas this was not 
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observed with spinophilin (Figure S1). Furthermore, neurabin overexpression is less than 
that of spinophilin (Figure S1). Like spinophilin, PP1 expression was not significantly 
different in the presence of CDK5 and neurabin (Figure 3D). Together these data suggest 
that in contrast to spinophilin, CDK5 decreases the association of overexpressed neurabin 
with endogenous PP1.
Spinophilin Phosphorylation by CDK5 at Ser17 Is Not Responsible for CDK5-Dependent 
Increases in the Spinophilin and PP1 Interaction.
We recently reported increased phosphorylation of spinophilin at the CDK5 site, Ser-17, and 
an increased association between spinophilin and PP1 in an animal model of PD.10 Phospho-
mimic (S17D) or nonphosphorylateable (S17A) mutations of spinophilin at the CDK5 site 
did not regulate the association of spinophilin with endogenous PP1α (Figure 4A) or PP1γ1 
(Figure 4B). Moreover, whereas there was a significant effect of CDK5 expression on the 
spinophilin interaction with PP1α (F(1,19) = 4.555; p = 0.0461) there was no effect of the 
mutation (S17A mutation vs WT; F(1,19) = 0.01012; p = 0.9209) (Figure 4C). This suggests 
that CDK5 phosphorylation of spinophilin at Ser17 is not responsible for the CDK5-
dependent increase in the spinophilin/PP1 association.
PP1 Phosphorylation Mimics Enhanced Spinophilin Binding.
PP1α is phosphorylated by CDK5 at Thr320.25,41 Upon alignment of rat PP1γ1 and human 
PP1α, Thr320 of PP1α is conserved in PP1γ1 (Thr311) (Figure 5A). Moreover, CDK5/p35 
overexpression increased the phosphorylation of overexpressed PP1α or PP1γ1 by 3.4 or 7-
fold, respectively (Figure S2B) when the phospho signal was normalized to the Myc signal. 
This antibody selectively detected phosphorylated PP1 as no band was observed in either 
T320A or T311A mutant PP1α or PP1γ1, respectively (Figure S2B). Therefore, we wanted 
to determine if phosphorylation at either Thr320 (PP1α) and/or Thr311 (PP1γ1) regulates 
the association between spinophilin and PP1. We generated T320A and T320D (PP1α) as 
well as T311A and T311D mutants (PP1γ1). Interestingly, the Asp mutations led to a robust 
(~8 kDa) molecular weight shift in PP1α (Figure 5B) but not PP1γ1 (Figure 5C). When 
normalized to Myc immunoreactivity in the input, the T320/311A mutants had no effect on 
the association of spinophilin with PP1; however, we found that the T320/311D mutations 
significantly increased the association of spinophilin with PP1α (Figure 5B; ANOVA values: 
F(2,9) = 10.14, p = 0.0049) and PP1γ1 (Figure 5C; ANOVA values F(2,9) = 14.53, p = 
0.0015). Therefore, phosphorylation of PP1 at its C-terminus by CDK5 may be partially 
responsible for the CDK5-dependent increase in the spinophilin/PP1 interaction.
To delineate the CDK5-dependent mechanisms that mediate the decreased PP1/neurabin 
association, we expressed neurabin with the PP1 CDK5 phosphorylation site mutants from 
above. As with spinophilin, the Thr320D mutation of PP1α also enhanced the association of 
neurabin with PP1α (Figure 5D; ANOVA values: F(2,9) = 14.45, p = 0.0015). This is in 
contrast to what was observed with CDK5 activity (Figure 3). However, neither the Thr311A 
nor the Thr311D mutation of PP1γ1 altered the association of neurabin with PP1γ1 (Figure 
5E; ANOVA values: F(2,9) = 2.459, p = 0.2891).
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CDK5 Activity and Spinophilin Association with PP1 Are Decreased by a High-Dose 
Regimen of METH.
Psychostimulant drugs of abuse such as METH modulate dopamine signaling; however, 
their effects on the spinophilin/PP1 interaction are unknown. Twenty-eight days following a 
high-dose, binge regimen of METH, striata were dissected from saline or METH-treated 
rats. Spinophilin was immunoprecipitated from striatal lysates. Striatal lysates and/or 
spinophilin immunoprecipitates were immunoblotted for tyrosine hydroxylase, spinophilin, 
PP1α, and CDK5 substrate phosphorylation (Figure 6A). This METH regimen lead to a 
significant ~25% decrease in tyrosine hydroxylase immunoreactivity (Figure 6B). While 
METH treatment had no effect on total spinophilin or PP1α levels (Figures 6C and D), we 
observed a decreased association of spinophilin with PP1α (Figure 6E). To begin to identify 
putative mechanisms for the regulation of this association, we immunoblotted spinophilin 
immunoprecipitates with an antibody that detects CDK5-phosphorylated substrates (Figure 
S2A). Concurrent with the decreased spinophilin/PP1 interaction, there was less CDK5 
substrate phosphorylation in the spinophilin immunoprecipitates in the region of the gel 
from 250 to 100 kDa (Figure 6F). There was one major band and four minor bands in this 
region (arrowheads). These data suggest that the spinophilin/PP1 interaction is decreased by 
a binge regimen of METH and that this decrease occurs concurrent with decreased CDK5 
substrate phosphorylation of spinophilin immunoprecipitates.
Spinophilin KO Mice Have Deficits in Rotarod Learning.
Previous studies have observed rotarod deficits in dopamine-depleted animals and following 
a neurotoxic regimen of METH. Moreover, loss of spinophilin is associated with enhanced 
sedative responses on the rotarod.42,43 However, the role of spinophilin in motor 
coordination and motor learning is not known. To assay rotarod behavior, control 
(spinophilin+/+) or whole-body spinophilin KO mice were placed on an accelerating rotarod 
apparatus. Three trials per day for three consecutive days were performed, and the latency to 
fall was recorded. All trials are shown in Figure 7A with the average of trials for each day 
shown in Figure 7B. A two-way ANOVA followed by a Sidak’s multiple comparison 
posthoc test was performed to compare across trials. Results revealed a significant trial 
effect (F(8,90) = 2.093; p = 0.0444) and a significant effect of genotype (F(1,90) = 54.08; p 
< 0.0001) with no interaction effect. A two-way ANOVA was performed on the average trial 
data shown in Figure 7B (day and genotype as variables). Results revealed a significant day 
effect (F(2,30) = 3.619; P = 0.0391) and a significant effect of genotype (F(1,30) = 30.57; p 
< 0.0001) with no interaction effect. When performing a Sidak’s posthoc test, all three days 
were significantly different between the control and KO groups. These data suggest that like 
both dopamine depletion and neurotoxic regimens of METH, spinophilin KO animals have 
impairments in rotarod behaviors and learning.
DISCUSSION
Spinophilin Interaction with PP1α is Decreased by a Neurotoxic Regimen of METH.
The association of PP1α10 and PP1γ19 with spinophilin is increased in an animal model of 
PD. While acute and sensitizing regimens of METH increase CDK5 activity,44 our data 
suggest that a neurotoxic regimen of METH leads to a long-term decrease in CDK5 
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substrate phosphorylation in spinophilin immunoprecipitates. Consistent with this decrease 
in activity, a previous proteomics study detected increases in the tyrosine nitration protein 
GSTP1, a molecule that is associated with decreasing CDK5 activity,45 following METH 
treatment.46 While animal models of PD have a complete or near complete loss of tyrosine 
hydroxylase immunoreactivity in the striatum 3 weeks following lesion,9,10 we observed a 
25% decrease in TH levels in METH-treated animals, suggesting less dopamine toxicity 
associated with neurotoxic METH treatment compared to nigral lesion. It is important to 
note that changes in TH levels may be due to acute alterations in dopamine that lead to 
compensatory changes in TH expression. However, given that these are persistent changes 
(observed 28 days after binge regimen of METH) and that TH immunoreactive dopamine 
terminals are lost following binge METH in mice,30 these changes may more likely be due 
to toxicity and not compensation. Moreover, these decreases in TH are in line with decreases 
observed in human chronic METH abusers.47 We observed a decreased association between 
spinophilin and PP1α in the striatum of METH-treated animals. One reason why opposite 
effects may occur in complete (e.g., >95% loss of dopamine neurons) vs partial lesion is that 
METH may increase the sensitivity to the dopamine that remains in the partial lesion. High-
dose binge regimens of METH have been shown to lead to decreases in the amplitude and 
frequency of dopamine release but increases in the duration of release.48 Moreover, high-
dose METH treatment leads to increases in D1 dopamine receptor (direct pathway) medium 
spiny neuron activity.49 Moreover, as is well-known, METH can cause reversal of the 
dopamine transporter and increases in dopamine release from vesicular pools; however, it is 
unlikely that these high levels of dopamine would persist for 28 days following the binge 
regimen. Therefore, METH treatment may lead to an increased sensitivity of striatal medium 
spiny neurons to the remaining dopamine as well as alterations in the mode of dopamine 
release.
PP1 Isoform Expression in HEK293 Cells.
While PP1α, PP1β, and PP1γ1 are highly enriched in the brain,16–19 and in particular 
forebrain vs cerebellum in human tissue,50 there are overlapping and unique expression 
patterns of the different PP1 isoforms (http://mouse.brain-map.org).15,20,39,51 Spinophilin 
preferentially associates with PP1α and PP1γ1 over PP1β.15,20 We observed that both PP1α 
and PP1γ1 isoforms were equally expressed in HEK293 cells. We were able to ascertain this 
as we could normalize the subunit selective antibody reactivity to total expression of each 
isoform by dividing the isoform antibody signal to the epitope-tag (Myc) antibody intensity 
of the specific overexpressed isoforms evaluated on the same samples. Overexpression of the 
specific PP1 isoform regulated the expression of the different endogenous PP1 isoforms with 
overexpression of PP1α increasing endogenous PP1α expression and decreasing 
endogenous PP1γ1 expression. Conversely, PP1γ1 overexpression increased endogenous 
PP1γ1 expression and decreased endogenous PP1α. However, the overexpression-dependent 
increase in PP1 expression of a band migrating at the endogenous molecular weight may be 
due to cleavage of the epitope tag. As an alternative explanation, it could be that PP1 levels 
positively modulate its own expression. Regardless, a cleavage product does not explain the 
PP1-mediated decrease in expression of the other PP1 isoform. PP1 is thought to be targeted 
to bind to DNA and regulate specific genes by PP1 interacting proteins such as NIPP1, 
PNUTS, and RepoMan as well as other unidentified proteins.52 Interestingly, NIPP1 was 
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shown to have different chromatin binding capabilities depending on its ability to bind to 
PP1. Moreover, there was isoform specificity in PP1 targeting to different chromatin sites.52 
Therefore, it is possible that a PP1α-bound form of a targeting subunit enhances the 
targeting subunit’s association with the PP1α promoter and causes it to be displaced from 
the PP1γ promoter. There is evidence for isoform specificity in PP1 targeting and regulation 
of PP1 activity20,21,53–56 as well as isoform specific differences in PP1 associations with 
different promoters,52 suggesting that unique targeting and transcriptional control may 
underlie PP1 autoregulation of its expression.
Spinophilin and Neurabin Association with PP1 is Differentially Regulated by CDK5.
CDK5 overexpression in a heterologous cell line increased the interaction between 
spinophilin and both PP1 isoforms. In contrast, CDK5 decreased the interaction of neurabin 
with PP1α and PP1γ1. CDK5 decreased the expression of both spinophilin (30%) and 
neurabin (64%). This is most likely not due to a loss of cells as we normalize to ponceau 
stain, and we did not see a significant decrease in endogenous PP1 expression under the 
different conditions. Neurabin, but not spinophilin, had a modest molecular weight shift in 
the presence of overexpressed CDK5 (Figure S1). This difference may be due to a different 
number of CDK5 phosphorylation sites on each protein or a different phosphorylation site. 
Spinophilin is known to be phosphorylated by CDK5 at Ser-17.24 While Neurabin has a 
conserved Ser-17, it is not phosphorylated by CDK5 at that site; rather, it is phosphorylated 
at Ser-95.57 While phosphorylation of Ser-17 on spinophilin does not have an effect on F-
actin binding, Ser-95 phosphorylation on neurabin does.24,57 CDK5 overexpression 
regulating spinophilin and neurabin stability is a plausible function of CDK5 as it has 
previously been shown that CDK5 overexpression decreased the stability of the protein 
CLOCK.58 In regard to CDK5-dependent regulation of protein stability, it may be that 
alterations in spinophilin and/or neurabin phosphorylation may directly regulate protein 
stability and/or may modulate ubiquitination of the protein. Whereas we did not see any 
laddering in the presence of CDK5, it may be that the molecular weight shift is too great to 
detect on this gel. Future studies will need to determine if CDK5 activity regulates 
spinophilin and neurabin protein stability in vivo and the mechanisms of this regulation.
Mechanisms Underlying CDK5-Dependent Increase in the Spinophilin Interaction with PP1.
Phosphomimic mutation (S17D) of spinophilin on its known CDK5-site, Ser17, had no 
effect on its association with PP1α or PP1γ1. In fact, if anything, the phosphomimic had a 
trend for a decreased association with both PP1 isoforms, suggesting that phosphorylation at 
this site is not responsible for the CDK5-dependent increase in association. PP1α is also 
phosphorylated by CDK5 at Thr320, and phosphorylation at this site is important in cellular 
differentiation.25 Specifically, Hou et al. found that overexpression of CDK5 along with p35 
in neuronal cultures increased PP1 phosphorylation at Thr320.41 Activation of synaptic 
NMDARs decrease CDK5 activity and consequently decrease PP1 phosphorylation at 
Thr320, leading to increased PP1 activity.41 Xia and colleagues also determined that 
NMDAR signaling increased the association between PP1 and inhibitor-2 and that these 
changes were due to alterations in inhibitor-2 phosphorylation.41 However, the role of PP1 
phosphorylation on modulating its interaction with spinophilin is unknown. While the 
overall structure of the PP1 isoforms is highly similar, the C-terminal regions of the different 
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isoforms diverge.59 However, both isoforms have a conserved Thr residue at Thr320 
RPITPPR (PP1α) or Thr311 RPVTPPR (PP1γ1).
Mutation of PP1 to an Asp at Thr320 (PP1α) caused a dramatic molecular weight shift in 
the migration of PP1α, but mutation at Thr311 did not affect the mobility of PP1γ1. These 
differences in migration may be due to variances in the sequence surrounding the 
phosphorylateable threonine. Specifically, in contrast to PP1γ1, PP1α has an additional 
stretch of 9 amino acid residues upstream of the phosphorylated threonine. Interestingly, one 
of these residues, a proline, is at the end of this stretch. This proline may allow for 
differential flexibility than that observed in PP1γ1. Interestingly, Asp substitutions at these 
sites increased the binding of spinophilin to PP1α and PP1γ1 when normalized to 
spinophilin levels in the IP and expression of the different PP1 mutants in the input. This 
normalization was performed as the Asp mutants had qualitatively less immunoreactivity 
than the WT or Ala mutants. This is consistent with qualitatively less immunoreactivity of 
overexpressed PP1α or PP1γ1 in the presence of overexpressed CDK5/p35. It is unclear 
why this is, but one possible explanation is that PP1 phosphorylation or TD mutation may 
modulate the stability of the protein. Spinophilin binds to multiple sites on PP1 in addition 
to the RVxF binding pocket.15 The Asp mutants on PP1 only increased spinophilin binding 
by approximately twofold, whereas CDK5 overexpression increased the association by 
approximately threefold. This could be due to the Asp mutants not fully recapitulating a 
phosphorylated threonine or additional CDK5-dependent changes occurring. CDK5 
regulates and/or is regulated by different kinases.60–62 Therefore, additional sites on 
spinophilin or PP1 that are regulated downstream of CDK5 overexpression (e.g., other 
kinases) may also contribute to the alterations in the spinophilin PP1 interaction. Moreover, 
given that T320/Thr311 phosphorylation of PP1α or PP1γ1 decreases PP1 activity and PP1 
can autodephosphorylate,25,41,63–65 we cannot rule out that the overexpression of 
differentially active PP1 may play a role in altering the spinophilin or neurabin association 
with PP1.
In contrast to spinophilin, CDK5 activity decreased the neurabin/PP1 interaction, an effect 
that was not due to PP1 phosphorylation as T311D on PP1γ1 had no effect on the 
association of PP1γ1 with neurabin and the T320D of PP1α actually enhanced PP1 binding 
to neurabin. This may be of interest as both spinophilin and neurabin bind to PP1 via their 
RVxF motifs but may have additional sites that can modulate this interaction. For instance, 
neurabin has a PKA-phosphorylateable residue near the PP1 binding domain that is lacking 
in spinophilin. This residue has been recently shown to modulate the association between 
neurabin and PP1.22 Moreover, CDK5-dependent differences in spinophilin and neurabin 
binding to different PP1 isoforms may modify competition in the association of PP1 with 
neurabin or spinophilin. This may be of interest as spinophilin and neurabin have both 
overlapping and differential expression patterns.1 Moreover, spinophilin and neurabin may 
heterodimerize,21 and therefore, altering binding to neurabin may regulate PP1 targeting to 
spinophilin. Therefore, there appear to be differential roles of mutation at the Thr311/320 
site in the two PP1 isoforms on modulating the association with these two, major neuronal 
PP1-targeting proteins. Moreover, given this complexity, we cannot rule out that additional 
mechanisms are contributing to dopamine depletion or METH toxicity-dependent 
modulation of the spinophilin/PP1 interaction.
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We observed decreases in CDK5 substrate phosphorylation in spinophilin 
immunoprecipitates in METH-treated samples. Whereas this antibody specifically detected 
CDK5-dependent phosphorylation as evidenced in HEK293 cells overexpressing CDK5 and 
p35 (Figure S2A), we cannot rule out that other CDKs or kinases that have similar 
phosphorylation motifs are also detected by this antibody. Future studies will need to 
directly test if Thr320 phosphorylation of PP1α and/or PP1γ1 is responsible for the 
decreased association between spinophilin and PP1 in METH-treated rodents.
Spinophilin Function in Modulating Behavioral Pathologies Associated with Dopamine 
Depletion and METH Toxicity.
The current biochemical data suggest CDK5-dependent regulation of the spinophilin PP1 
interaction. Moreover, these studies suggest differences in CDK5 substrate phosphorylation 
in spinophilin immunoprecipitates isolated from METH-treated rats as well as decreases in 
the spinophilin–PP1 interaction under these conditions. Behaviorally, both METH 
toxicity30,31 and dopamine depletion32 lead to deficits in rotarod balance and learning. 
Interestingly, we observed deficits in both basal rotarod performance and delays in motor 
learning in whole-body spinophilin KO mice. These data further demonstrate a role of 
spinophilin in mediating striatal behaviors such as motor learning. Given that spinophilin is 
the most abundant PP1 targeting protein in the PSD,33 alterations in spinophilin-dependent 
PP1 targeting may underlie these pathologies. Furthermore, given that the spinophilin/PP1 
interaction is enhanced in animal models of PD9,10 and decreased in METH toxicity (present 
study), we posit that biphasic regulation of spinophilin’s association with PP1 has 
deleterious effects. A decreased interaction between spinophilin and PP1 may attenuate 
targeting of PP1 and enhance phosphorylation of its substrates.8 Conversely, increased 
association of spinophilin with PP1 may lead to decreases in PP1 activity as spinophilin is 
known to prevent PP1 activity toward specific substrates.15
Taken together, our data demonstrate mechanisms by which the spinophilin/PP1 interaction 
are regulated and suggest an influential role of spinophilin on modulating striatal behaviors.
METHODS
Animals.
Male Sprague–Dawley rats (180–275 g, Harlan, Indianapolis, IN) were used for METH 
treatment studies. For rotarod studies, 3–5.5-month old male spinophilin KO (B6N(Cg)-
Ppp1r9btm1.1(KOMP)Vlcg/J N = 6) or male (N = 4) or female (N = 2) control, WT littermate 
mice were used. All animal studies were performed in accordance with the Guide for the 
Care and Use of Laboratory Animals as disseminated by the U.S. National Institutes of 
Health and were approved by Indiana University School of Medicine and/or Indiana 
University–Purdue University School of Science Animal Care and Use Committees.
METH Treatment.
Rats were i.p. injected with 4 doses of METH (10 mg/kg, Sigma, St. Louis, MO, Cat. 
M8750) or saline (1 mL/kg), once every 2 h for 4 total injections, as previously described.66
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DNA Plasmids and Mutagenesis.
Mammalian expression constructs were amplified by PCR and inserted into pDonr221 
(ThermoFisher Scientific, Waltham, MA) using Gateway cloning with BP recombinase 
(ThermoFisher Scientific). Following insertion of the cDNA encoding different proteins (see 
below) into the donor vector, the cDNAs in the donor vectors were recombined into the 
mammalian expression vector, pcDNA3.1 nDEST, containing different N-terminal epitope 
tags (V5, Myc, HA, or Flag) using LR recombinase. The following cDNAs were used as 
templates to generate the mammalian expression vectors: human spinophilin10 (Addgene no. 
87122), neurabin (isoform-4; Transomic Technologies, Huntsville, AL BC130449-
TCH1003), rat PP1γ1,20 human PP1α (PBC004482, Transomic Technologies), human 
CDK5 (Addgene no. 23699), and human p35 (Addgene no. 23779). CDK5 and p35 were 
gifts from William Hahn and David Root67 and obtained from Addgene. Mutagenesis to 
generate PP1 mutants was performed as previously described.10 DNA quantification was 
performed on a Cytation3 imager (BioTek, Winooski, VT). DNA inserts and mutations were 
sequence verified (Genewiz, South Plainfield, NJ).
Transfections.
Human embryonic kidney cells (HEK293FT; ThermoFisher) were cultured in Dulbecco’s 
modified Eagle’s medium (DMEM) that contained 10% fetal bovine serum, 584 mg/L L-
glutamine, 1 mM sodium pyruvate, 100 U/mL penicillin, and 100 μg/mL streptomycin. 
Culture flasks were incubated at a constant 37 °C and 5% CO2 (Panasonic Healthcare; 
Secaucus, NJ). Cells were transfected with appropriate DNAs and PolyJet reagent 
(SignaGen Laboratories, Gaithersburg, MD) as per the manufacturers’ instructions.
Cell Lysis.
For spinophilin immunoprecipitates from METH-treated rats, one rat striatum was 
homogenized and sonicated in 2 mL of a modified radio-immunoprecipitation assay (RIPA) 
buffer containing 20 mM Tris, 150 mM NaCl, 2 mM EDTA, protease inhibitor cocktail 
(ThermoFisher Scientific or Bimake, Houston, TX), phosphatase inhibitors (20 mM sodium 
fluoride, 20 mM sodium orthovanadate, 20 mM β-glycerophosphate, and 10 mM sodium 
pyrophosphate; Sigma-Aldrich or ThermoFisher Scientific), 1% NP-40 (v/v; ThermoFisher 
Scientific), 1% sodium deoxycholate (w/v; ThermoFisher Scientific). Following overnight 
transfection, HEK293 cells were sonicated in 1.6 mL KCl lysis buffer (150 mM KCl, 1 mM 
DTT, 2 mM EDTA, 50 mM Tris-HCl, pH 7.5, 1% (v/v) Triton X-100, 20 mM NaF, 20 mM 
β-glycerophosphate, 20 mM NaVO3, 10 mM Na pyrophosphate, 1× protease inhibitor 
cocktail) or low-ionic strength Tris buffer (10 mM DTT, 5 mM EDTA, 2 mM Tris-HCl pH 
7.5, 1% Triton X-100 with protease and phosphatase inhibitors as above).
Immunoprecipitations.
Spinophilin or HA-tagged spinophilin or neurabin were immunoprecipitated from rat brain 
or HEK293 cell lysates, respectively, as previously described.10 Endogenous spinophilin was 
immunoprecipitated from 37.5% of the total rat lysate using 3 μg of a goat spinophilin 
polyclonal antibody (Santa Cruz Biotechnology, Dallas TX; SC-14774). HA-tagged 
spinophilin or neurabin was immunoprecipitated from 50% of the total HEK293 cell lysate 
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using 1–2 μg of a goat HA polyclonal antibody (Bethyl Laboratories, Montgomery, TX; 
A190–238A).
Immunoblotting.
For the METH experiments evaluating spinophilin immunoprecipitates, 1% of the input and 
25% of the spinophilin immunoprecipitates were immunoblotted for spinophilin and PP1. 
For HEK293 studies, 0.5–1.5% of the input and 25–33% of the immunoprecipitates were 
immunoblotted with the appropriate primary antibody (see below). These studies were 
performed similar to previously described.10 For protein detection, the following primary 
antibodies were used: spinophilin: rabbit polyclonal HA (Santa Cruz Biotechnology, 
SC-805), goat polyclonal HA, goat spinophilin, or rabbit monoclonal spinophilin (Cell 
Signaling Technology, Danvers, MA; 14136S); rabbit monoclonal CDK5 substrate motif 
antibody (Cell Signaling Technology, 9477); rabbit Thr320 phsopho-PP1 antibody (Cell 
Signaling Technology, 2581); mouse monoclonal Myc epitope tag antibody (Santa Cruz 
Biotechnology, sc-40) or goat Myc (Bethyl A190–104A), goat polyclonal PP1γ antibody 
(Santa Cruz Biotechnology, SC-6108), mouse monoclonal PP1α antibody (Santa Cruz 
Biotechnology, SC-7482), rabbit tyrosine hydroxylase (TH; Santa Cruz Biotechnology, 
SC-14007), rabbit DDDDK (Flag) antibody (Bethyl A190–102A), mouse Flag antibody 
(Sigma-Aldrich F3165), Thr320 PP1α antibody (Cell Signaling Technology, 2581; 
previously validated25,41). Antibody dilutions were used at 1:500–1:2000 for 
immunoblotting. Following overnight incubation at 4 °C, the following secondary antibodies 
were used for fluorescence detection: Donkey anti goat IgG (H+L) Alexa Fluor 790 (Life 
Technologies A11370; 1:10 000 dilution), donkey anti mouse IgG (H +L) Alexa Fluor 790 
(Jackson Immunoresearch, West Grove, PA, no. 715-655-151, 1:50 000 dilution), Donkey 
anti rabbit IgG (H+L) Alexa Fluor 790 (Jackson Immunoresearch no. 711-655-152, 1:50 000 
dilution). Donkey anti goat Alexa Fluor 680 (Life Technologies A21084; 1:10 000 dilution). 
Imaging was performed on an Odyssey CLx system (LI-COR Biosicences, Lincoln, NE). 
Images were acquired under automatic mode to ensure a linear range. No saturated pixels 
were detected. Moreover, ponceau staining was shown to be linear between 0.63 μg and 78 
μg of total protein lysate (striatal lysates) and fluorescence immunoblotting was shown to be 
linear for spinophilin, PP1α, and PP1γ1 (0.13–78.3 μg total protein lysate) (Figure S3).
Rotarod.
For the accelerating rotarod (3 cm width); male whole-body spinophilin KO (spinophilin 
− / −; B6N (Cg) - Ppp1r9btm1.1(KOMP)Vlcg/J) or male or female control wild-type mice were 
placed on the Rotamex-5 (Columbus Instruments) apparatus. Mice were subjected to an 
accelerating rotarod (4–40 rpm in 300 s) for 3 successive trials on 3 consecutive days. A 
series of photocell beams located above the rotating rod with a temporal resolution of 0.1 
rpm (0.1 cm/sec) detected when the mouse was no longer on the rod. To circumvent any 
false fall recordings, any mouse that was able to grip the bar and rotate with the bar for 2 
rotations or greater was considered to have failed the trial and the recording was not used. 
Latency to fall was documented for each mouse, and a 120–180 s rest was given to all mice 
before the next trial.
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Data Analysis and Statistics.
For HEK293 cell experiments, each experiment was run on a separate gel, and each data 
point is a separate transfection, performed in a separate set of 25 cm2 flasks isolated on a 
separate day or on the same day from a separate 75 cm2 parent flask. To calculate total 
protein expression, the fluorescence value derived from a specific antibody (e.g., HA) was 
divided by the value generated from the same ponceau stained membrane. To quantify the 
corresponding ponceau-stained lane, a portion of the lane was measured using Image J. For 
quantitation of lysates, ~10 μg of total protein was loaded. Similar total protein 
concentrations as we were loading have been shown to generate a linear signal by ponceau 
staining (Figure S3 and ref 68). The ponceau stain value was used to normalize loading for 
endogenous proteins. To compare across multiple gels, the value of the experimental group 
was normalized to the value of the control group on each immunoblot. Therefore, no error 
was obtained for the control conditions. For METH spinophilin immunoprecipitation 
experiments, an N of 3 animals was immunoblotted on one gel and a separate N of 3 animals 
was evaluated on a separate gel. A ratio was generated from each gel to obtain error bars for 
both saline and METH treated samples. To statistically analyze each experimental group, a 
1-sample t-test was used to compare each experimental group to a theoretical mean of 1. For 
comparing the effect of CDK5 expression on WT and S17A mutant spinophilin, a two-way 
ANOVA was performed. For comparing across the three different PP1 mutations (WT, TA, 
and TD), a one-way ANOVA followed by a Tukey’s multiple comparison posthoc test was 
performed. For the rotarod studies, a two-way ANOVA followed by a Holm–Sidak multiple 
comparison posthoc test was performed to compare control and spinophilin KO across the 
different trials or days. Statistical analyses and graphing were performed using Prism 6.0 
(GraphPad, LaJolla, CA). Graphs and immunblotting images were assembled using 
Photoshop and Illustrator (Adobe Systems Incorporated, San Jose, CA).
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ACKNOWLEDGMENTS
We thank Drs. Andy Hudmon (Indiana University School of Medicine) and Roger Colbran (Vanderbilt University) 
for critical discussion of the manuscript. We thank Mr. Victor Olafusi for help in generation of the PP1 mutants.
Funding
Support for these studies was from NIH (Grants K01NS073700 and R21DA041876 to A.J.B.), Department of 
Biology Start-up funds (to A.J.B.), and a Summer Undergraduate Research Program Fellowship (C.W.M.).
ABBREVIATIONS
PP1 protein phosphatase 1
METH methamphetamine
PD Parkinson’s disease
CDK5 cyclin-dependent kinase 5
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HEK293 human embryonic kidney 293FT cells
PSD postsynaptic density
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Figure 1. 
PP1α and PP1γ1 are both endogenously expressed in HEK293 cells, and overexpression of 
PP1 regulates endogenous PP1 expression. (A) Myc-tagged PP1α or PP1γ1 was 
overexpressed in HEK293 cells and immunoblotted with a Myc antibody, a PP1α selective 
antibody, or a PP1γ1 selective antibody. (B) The PP1α selective antibody was ~31.3-fold 
more robust at detecting PP1α over PP1γ1 when normalized to Myc signal. Conversely, the 
PP1γ1 selective antibody was 13.5-fold more robust at detecting PP1γ1 over PP1α. (C) 
Upon normalizing to Myc intensity (to normalize for differences in antibody detections) and 
loading, the PP1α and PP1γ1 antibodies detected equal concentrations of PP1α and PP1γ1. 
(D) PP1α overexpression increased the expression of endogenous PP1α but decreased the 
expression of endogenous PP1γ1. Conversely, PP1γ1 overexpression increased the 
expression of endogenous PP1γ1 but decreased the expression of endogenous PP1α. A 1-
sample t-test comparing to a theoretical value of 1 was performed. *p < 0.05, ***p < 0.001.
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Figure 2. 
CDK5 increases the association between spinophilin and PP1 and decreases spinophilin 
expression. (A) HEK293 cells were transfected with spinophilin in the absence or presence 
of CDK5 and its activator, p35. Lysates and spinophilin immunoprecipitates were 
immunoblotted for spinophilin, PP1α, PP1γ1, Myc epitope, and Flag epitope. For lysates, 
0.5% of the total was loaded for spinophilin and PP1 blots and 1.5% was loaded for Flag and 
Myc blots. (B) The association between spinophilin and PP1α or PP1γ1 was significantly 
increased by overexpression of CDK5/p35. (C) Spinophilin expression was decreased by 
CDK5/p35 overexpression. (D) PP1 expression was unchanged by CDK5/p35 
overexpression. A 1-sample t-test comparing to a theoretical value of 1 was performed. *p < 
0.05, **p < 0.01.
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Figure 3. 
CDK5 decreases the association between neurabin and PP1 and decreases neurabin 
expression. (A) HEK293 cells were transfected with neurabin in the absence or presence of 
CDK5 and its activator, p35. Lysates and neurabin immunoprecipitates were immunoblotted 
for neurabin, PP1α, PP1γ1, Myc epitope, and Flag epitope. For lysates, 0.5% of the total 
was loaded for spinophilin and PP1 blots and 1.5% was loaded for Flag and Myc blots. (B) 
The association between neurabin and PP1α or PP1γ1 was significantly decreased by 
overexpression of CDK5/p35. (C) Neurabin expression was decreased by CDK5/p35 
overexpression. (D) PP1 expression was unchanged by CDK5/p35 overexpression. A 1-
sample t-test comparing to a theoretical value of 1 was performed. *p < 0.05, **p < 0.01, 
****p < 0.0001.
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Figure 4. 
Spinophilin association with PP1 was not regulated by Ser17 mutations of spinophilin. 
HEK293 cells were transfected with WT, S17A, or S17D spinophilin and 
immunoprecipitated for spinophilin. Lysates and immunoprecipitates were immunoblotted 
for spinophilin and either (A) PP1α or (B) PP1γ1. There was no effect of the mutations on 
spinophilin association with PP1. (C) HEK293 cells were transfected with WT or S17A 
spinophilin in the absence or presence of CDK5/p35 and immunoprecipitated for 
spinophilin. Lysates and immunoprecipitates were immunoblotted for spinophilin and PP1α. 
S17A mutation had no effect on the CDK5-dependent increase in spinophilin binding to 
PP1. For lysates, 0.5% (A and C) or 1.33% (B) of the total was loaded for spinophilin and 
PP1 blots. For immunoprecipitates, 25% (A and C) or 33% (B) of the immunoprecipitate 
was loaded. A one-way (A and B) or a two-way ANOVA (C) was performed.
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Figure 5. 
PP1 Thr320/311mutants had increased association with spinophilin. (A) Alignment of PP1 
(human PP1α and rat PP1γ1). (B) HEK293 cells were transfected with spinophilin and WT, 
T320A, or T320D PP1α and immunoprecipitated for spinophilin. The association of 
spinophilin was greater with T320D compared to WT or T320A PP1α. (C) HEK293 cells 
were transfected with spinophilin and WT, T311A, or T311D PP1γ1 and 
immunoprecipitated for spinophilin. The association of T311D was greater than WT or 
T320A mutant. (D) HEK293 cells were transfected with neurabin and WT, T320A, or 
T320D PP1α and immunoprecipitated for neurabin. The association of neurabin was greater 
with T311D compared to WT or T311A. (E) HEK293 cells were transfected with neurabin 
and WT, T3110A, or T311D PP1γ1 and immunoprecipitated for neurabin. There was no 
change in the association of neurabin with the different PP1γ1 mutants. A one-way ANOVA 
followed by a Tukey posthoc test was performed. *p < 0.05, **p < 0.01.
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Figure 6. 
Spinophilin/PP1α interaction and CDK5 phosphorylation of spinophilin binding proteins is 
decreased following a neurotoxic regimen of METH. Striatal lysates from rats treated with 4 
doses of saline or METH (10 mg/kg) were immunoprecipitated for spinophilin (A–F) or PP1 
(G–H). (A) Lysates (0.75% of total homogenate) were immunoblotted for spinophilin, PP1, 
and TH, whereas spinophilin immunoprecipitates (9.4% of total input) were immunoblotted 
for spinophilin, PP1α, and phosphorylated CDK substrates. (B–D) Total levels of TH (B), 
spinophilin (C), and PP1α (D) were not significantly different. (E) The association between 
spinophilin and PP1α was decreased. (F) The amount of CDK5 substrate phosphorylation in 
the spinophilin immunoprecipitates was decreased. **p < 0.01.
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Figure 7. 
Spinophilin KO mice have deficits in motor learning. Control or KO spinophilin mice were 
placed on an accelerating rotarod, and their latency to fall was measured. (A) Data showing 
all three trials from each day are shown. (B) Data showing average of the 3 trials from each 
day. A Holm–Sidak posthoc multiple comparison test was performed to compare Two-way 
ANOVA data for WT and KO latencies from each trial (A) or by day for pooled trial data 
(B). *p < 0.05, **p < 0.01, ***p < 0.001.
Edler et al. Page 25
ACS Chem Neurosci. Author manuscript; available in PMC 2020 February 11.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
